Richard and Marilyn Witham Professor of Ophthalmology and Visual Sciences
Associate Professor of Ophthalmology and Visual Sciences
Ophthalmology & Visual Sciences
1000 Wall Street
Ann Arbor, MI 48105
[email protected]
1000 Wall Street
Ann Arbor, MI 48105
Available to mentor
Grant M Comer
Clinical Associate Professor
Dr. Grant Comer is an ophthalmologist in Ann Arbor, Michigan and is affiliated with multiple hospitals in the area, including University of Michigan Health-Ann Arbor and Veterans Affairs Ann Arbor Healthcare System. He received his medical degree from Indiana University School of Medicine and has been in practice for more than 20 years. Dr. Grant Comer has expertise in treating cataract, retinal detachment, glaucoma, among other conditions - see all areas of expertise. Dr. Grant Comer accepts Medicare, Aetna, Humana, Blue Cross, United Healthcare - see other insurance plans accepted.
-
Yasvoina M, Yang Q, Woods SM, Heeren T, Comer GM, A Egan C, Fruttiger M. Br J Ophthalmol, 2023 Nov; 107 (11): 1736 - 1743.Journal ArticleIntraretinal pigmented cells in retinal degenerative disease.
DOI:10.1136/bjophthalmol-2021-320392 PMID: 35301216 -
Apkarian AO, Comer G. 2008Additional ScholarshipRetinal Detachment
-
Prasov L, Guan B, Ullah E, Archer SM, Ayres BM, Besirli CG, Wiinikka-Buesser L, Comer GM, Del Monte MA, Elner SG, Garnai SJ, Huryn LA, Johnson K, Kamat SS, Lieu P, Mian SI, Rygiel CA, Serpen JY, Pawar HS, Brooks BP, Moroi SE, Richards JE, Hufnagel RB. Sci Rep, 2020 Nov 17; 10 (1): 19986Journal ArticleNovel TMEM98, MFRP, PRSS56 variants in a large United States high hyperopia and nanophthalmos cohort.
DOI:10.1038/s41598-020-76725-8 PMID: 33203948 -
Hutton DW, Stein JD, Glassman AR, Bressler NM, Jampol LM, Sun JK, DRCR Retina Network . JAMA Ophthalmol, 2019 Dec 1; 137 (12): 1424 - 1432.Journal ArticleFive-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
DOI:10.1001/jamaophthalmol.2019.4284 PMID: 31647496 -
Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, Heeren TF, Peto T, Clemons TE, Chew EY, Bird AC, Sallo FB, MacTel Study Group . Acta Ophthalmol, 2019 Nov; 97 (7): e998 - e1005.Journal ArticleProgression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
DOI:10.1111/aos.14110 PMID: 30968592 -
Baker CW, Glassman AR, Beaulieu WT, Antoszyk AN, Browning DJ, Chalam KV, Grover S, Jampol LM, Jhaveri CD, Melia M, Stockdale CR, Martin DF, Sun JK, DRCR Retina Network . JAMA, 2019 May 21; 321 (19): 1880 - 1894.Journal ArticleEffect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.
DOI:10.1001/jama.2019.5790 PMID: 31037289 -
Chew EY, Clemons TE, Jaffe GJ, Johnson CA, Farsiu S, Lad EM, Guymer R, Rosenfeld P, Hubschman J-P, Constable I, Wiley H, Singerman LJ, Gillies M, Comer G, Blodi B, Eliott D, Yan J, Bird A, Friedlander M, Macular Telangiectasia Type 2-Phase 2 CNTF Research Group . Ophthalmology, 2019 Apr; 126 (4): 540 - 549.Journal ArticleEffect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.
DOI:10.1016/j.ophtha.2018.09.041 PMID: 30292541 -
Leung I, Sallo FB, Bonelli R, Clemons TE, Pauleikhoff D, Chew EY, Bird AC, Peto T, MacTel Study Group . Retina, 2018 Jan; 38 Suppl 1 (Suppl 1): S43 - S50.Journal ArticleCHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
DOI:10.1097/IAE.0000000000001842 PMID: 29095354
